GetTopicDetailResponse(id=12d06834136, topicName=王碧蕓, introduction=王碧蕓, content=null, image=null, comments=5, allHits=1192, url=https://h5.medsci.cn/topic?id=68341, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=98477, tagList=[TagDto(tagId=98477, tagName=王碧蕓)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1986226, encodeId=1257198622621, content=<a href='/topic/show?id=12d06834136' target=_blank style='color:#2F92EE;'>#王碧蕓#</a>, objectTitle=Nat Commun：復旦大學王碧蕓/胡夕春團隊發(fā)現(xiàn)轉(zhuǎn)移性三陰性乳腺癌的高效聯(lián)合化療方案, objectType=article, longId=733030, objectId=73fbe3303097, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73fbe3303097, replyNumber=0, likeNumber=0, createdTime=2022-07-31, rootId=0, userName=爆笑小醫(yī), userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73fbe3303097, moduleTitle=Nat Commun：復旦大學王碧蕓/胡夕春團隊發(fā)現(xiàn)轉(zhuǎn)移性三陰性乳腺癌的高效聯(lián)合化療方案, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=73fbe3303097)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986225, encodeId=1f77198622537, content=<a href='/topic/show?id=12d06834136' target=_blank style='color:#2F92EE;'>#王碧蕓#</a>, objectTitle=Molecular Cancer:復旦大學陳舌團隊，張思團隊聯(lián)合附屬腫瘤醫(yī)院王碧蕓團隊、公共衛(wèi)生學院付朝偉團隊提供高敏感性、非侵入性腫瘤化療液體活檢標記物, objectType=article, longId=294294, objectId=c649294294ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c649294294ec, replyNumber=0, likeNumber=106, createdTime=2022-09-27, rootId=0, userName=爆笑小醫(yī), userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c649294294ec, moduleTitle=Molecular Cancer:復旦大學陳舌團隊，張思團隊聯(lián)合附屬腫瘤醫(yī)院王碧蕓團隊、公共衛(wèi)生學院付朝偉團隊提供高敏感性、非侵入性腫瘤化療液體活檢標記物, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c649294294ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986224, encodeId=8111198622428, content=<a href='/topic/show?id=12d06834136' target=_blank style='color:#2F92EE;'>#王碧蕓#</a>, objectTitle=王碧蕓：2019年晚期乳腺癌治療盤點, objectType=article, longId=185749, objectId=2241185e4914, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2241185e4914, replyNumber=0, likeNumber=0, createdTime=2020-05-23, rootId=0, userName=爆笑小醫(yī), userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2241185e4914, moduleTitle=王碧蕓：2019年晚期乳腺癌治療盤點, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2241185e4914)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986223, encodeId=3bf11986223bf, content=<a href='/topic/show?id=12d06834136' target=_blank style='color:#2F92EE;'>#王碧蕓#</a>, objectTitle=王碧蕓：2019年HER2+乳腺癌進展盤點, objectType=article, longId=185748, objectId=71c5185e48fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71c5185e48fd, replyNumber=0, likeNumber=121, createdTime=2020-12-13, rootId=0, userName=爆笑小醫(yī), userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71c5185e48fd, moduleTitle=王碧蕓：2019年HER2+乳腺癌進展盤點, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=71c5185e48fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986222, encodeId=89681986222d9, content=<a href='/topic/show?id=12d06834136' target=_blank style='color:#2F92EE;'>#王碧蕓#</a>, objectTitle=王碧蕓：三陰性乳腺癌輔助新輔助治療進展, objectType=article, longId=56657, objectId=e21b5665e84, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e21b5665e84, replyNumber=0, likeNumber=96, createdTime=2015-11-12, rootId=0, userName=爆笑小醫(yī), userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e21b5665e84, moduleTitle=王碧蕓：三陰性乳腺癌輔助新輔助治療進展, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e21b5665e84)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
